The Annual Stockholders Meeting of Spectros Corporation was held 2 months ago.
Overall, the highlights of the meeting were as follows:

-- In the voting that occurred during the formal part of the meeting, the Board was re-elected without a single dissenting vote cast, and an amendment was approved to the Articles of the Company to reconfigure the Board of Directors to permit two Series A directors, two Common directors, and one outside director. Israel Beinglass is the Silicon Ventures series A director.

-- The extensive regulatory, manufacturing, and sales efforts were discussed, including discussing the production facilities, the successful handling of the FDA, CE, and other regulatory visits, and the use of internet-based sales software to facilitate demos, technical inservicing, and clinical support.

-- Assessment of 2007was discussed , including the increasing adoption of T-Stat in clinical use and increasing numbers of evaluation placements of the devices.